JP2019081762A5 - - Google Patents

Download PDF

Info

Publication number
JP2019081762A5
JP2019081762A5 JP2018238486A JP2018238486A JP2019081762A5 JP 2019081762 A5 JP2019081762 A5 JP 2019081762A5 JP 2018238486 A JP2018238486 A JP 2018238486A JP 2018238486 A JP2018238486 A JP 2018238486A JP 2019081762 A5 JP2019081762 A5 JP 2019081762A5
Authority
JP
Japan
Prior art keywords
alkyl
fluoroalkyl
cycloalkyl
alkoxy
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018238486A
Other languages
English (en)
Japanese (ja)
Other versions
JP6632701B2 (ja
JP2019081762A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019081762A publication Critical patent/JP2019081762A/ja
Publication of JP2019081762A5 publication Critical patent/JP2019081762A5/ja
Application granted granted Critical
Publication of JP6632701B2 publication Critical patent/JP6632701B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018238486A 2012-10-12 2018-12-20 ベンズアミド Expired - Fee Related JP6632701B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261713113P 2012-10-12 2012-10-12
US61/713,113 2012-10-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015536142A Division JP6515409B2 (ja) 2012-10-12 2013-10-11 ベンズアミド

Publications (3)

Publication Number Publication Date
JP2019081762A JP2019081762A (ja) 2019-05-30
JP2019081762A5 true JP2019081762A5 (enExample) 2019-07-04
JP6632701B2 JP6632701B2 (ja) 2020-01-22

Family

ID=49551580

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015536142A Expired - Fee Related JP6515409B2 (ja) 2012-10-12 2013-10-11 ベンズアミド
JP2018238486A Expired - Fee Related JP6632701B2 (ja) 2012-10-12 2018-12-20 ベンズアミド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015536142A Expired - Fee Related JP6515409B2 (ja) 2012-10-12 2013-10-11 ベンズアミド

Country Status (42)

Country Link
US (4) US9102591B2 (enExample)
EP (1) EP2906546B1 (enExample)
JP (2) JP6515409B2 (enExample)
KR (1) KR20150067188A (enExample)
CN (1) CN104884445B (enExample)
AP (1) AP2015008406A0 (enExample)
AR (1) AR092973A1 (enExample)
AU (1) AU2013328584B2 (enExample)
BR (1) BR112015008117A2 (enExample)
CA (1) CA2887096C (enExample)
CL (1) CL2015000902A1 (enExample)
CR (1) CR20150171A (enExample)
CY (1) CY1120008T1 (enExample)
DK (1) DK2906546T3 (enExample)
DO (1) DOP2015000076A (enExample)
EA (1) EA026396B1 (enExample)
EC (1) ECSP15013883A (enExample)
ES (1) ES2662523T3 (enExample)
GE (1) GEP201706621B (enExample)
HR (1) HRP20180272T1 (enExample)
HU (1) HUE038223T2 (enExample)
IL (1) IL237914A0 (enExample)
LT (1) LT2906546T (enExample)
MA (1) MA37990B1 (enExample)
ME (1) ME02982B (enExample)
MX (1) MX369717B (enExample)
NI (1) NI201500050A (enExample)
NO (1) NO2851818T3 (enExample)
NZ (1) NZ630830A (enExample)
PE (1) PE20150709A1 (enExample)
PH (1) PH12015500746A1 (enExample)
PL (1) PL2906546T3 (enExample)
PT (1) PT2906546T (enExample)
RS (1) RS56925B1 (enExample)
RU (1) RU2015113320A (enExample)
SG (1) SG11201502680QA (enExample)
SI (1) SI2906546T1 (enExample)
SM (1) SMT201800136T1 (enExample)
TN (1) TN2015000107A1 (enExample)
TR (1) TR201802992T4 (enExample)
TW (1) TWI598325B (enExample)
WO (1) WO2014057078A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI598325B (zh) * 2012-10-12 2017-09-11 H 朗德貝克公司 苯甲醯胺類
TW201427947A (zh) 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺
PL2931717T3 (pl) 2012-12-12 2017-05-31 Actelion Pharmaceuticals Ltd. Pochodne indolokarboksyamidu jako antagoniści receptora p2x7
AR094053A1 (es) 2012-12-18 2015-07-08 Actelion Pharmaceuticals Ltd Derivados de indol carboxamida como antagonistas del receptor p2x₇
EP2956457B1 (en) 2013-01-22 2016-11-23 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
ES2616114T3 (es) 2013-01-22 2017-06-09 Actelion Pharmaceuticals Ltd. Derivados de amida heterocíclica como antagonistas del receptor P2X7
CN105503787A (zh) * 2015-12-31 2016-04-20 阜阳欣奕华材料科技有限公司 一种索非布韦中间体的纯化方法
CN106366056B (zh) * 2016-08-26 2018-12-11 常州市阳光药业有限公司 3-氨甲基四氢呋喃的制备方法
SI3609868T1 (sl) * 2017-03-13 2024-03-29 Raqualia Pharma Inc. Derivati tetrahidrokinolina kot antagonisti receptorja P2X7
WO2019226213A2 (en) 2018-03-08 2019-11-28 Incyte Corporation AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
MA55805A (fr) 2019-05-03 2022-03-09 Flagship Pioneering Innovations V Inc Métodes de modulation de l'activité immunitaire
CN117088877A (zh) * 2020-10-28 2023-11-21 杭州阿诺生物医药科技有限公司 一种高活性Wnt通路抑制剂化合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445707A1 (de) 1962-05-05 1969-03-13 Hoechst Ag Piperidinverbindungen und Verfahren zu ihrer Herstellung
US3435038A (en) * 1965-06-01 1969-03-25 Sandoz Ag 5,6,7,9,10,14b-hexahydroisoquinolo (2,1-d) benzo (1,4) diazepines
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
SE0003476D0 (sv) * 2000-09-28 2000-09-28 Astrazeneca Ab Compounds
TW200300083A (en) 2001-11-12 2003-05-16 Pfizer Prod Inc Benzamide, heteroarylamide and reverse amides
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
PA8591801A1 (es) * 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
ATE355273T1 (de) * 2003-05-12 2006-03-15 Pfizer Prod Inc Benzamidinhibitoren des p2x7-rezeptors
AU2004263179B8 (en) 2003-08-08 2011-07-14 Vertex Pharmaceuticals Incorporated Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
TWI368482B (en) 2003-12-19 2012-07-21 Bayer Sas New 2-pyridinylethylbenzamide derivatives
EP1729772B8 (en) 2004-03-24 2017-04-19 Merck Sharp & Dohme Corp. Heteroaryl piperidine glycine transporter inhibitors
JP2008504363A (ja) * 2004-06-29 2008-02-14 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー P2x7受容体のベンズアミド阻害剤を利用する併用療法
ATE476431T1 (de) * 2004-12-21 2010-08-15 Merck Sharp & Dohme Piperidin- und azetidinderivate als glyt1- inhibitoren
WO2006080884A1 (en) * 2005-01-27 2006-08-03 Astrazeneca Ab Novel biaromatic compounds, inhibitors of the p2x7-receptor
CA2611376C (en) * 2005-06-13 2013-09-10 Merck Sharp & Dohme Limited Therapeutic agents
CA2625039A1 (en) 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
JP2009057282A (ja) 2005-12-19 2009-03-19 Astellas Pharma Inc カルボン酸誘導体又はその塩
TWI435863B (zh) * 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd N-2-(雜)芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
RU2010103102A (ru) * 2007-07-02 2011-08-10 Зингента Партисипейшнс Аг (Ch) Новые микробиоциды
US8642660B2 (en) * 2007-12-21 2014-02-04 The University Of Rochester Method for altering the lifespan of eukaryotic organisms
JP5369173B2 (ja) * 2008-04-22 2013-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キノリン若しくはイソキノリン置換p2x7アンタゴニスト
ES2345527B1 (es) * 2008-10-08 2011-09-08 Hospital Clinic I Provincial De Barcelona Sustancias bloqueadoras de los canales kv 1.3 para el tratamiento de enfermedades asociadas a hiperplasia de la intima.
CA2804716A1 (en) 2010-07-12 2012-01-19 Pfizer Limited Chemical compounds
CA2828060C (en) * 2011-03-02 2018-11-06 The University Of Tokyo Endoparasite control agent
RU2608217C2 (ru) * 2011-11-02 2017-01-17 Байер Интеллектуэль Проперти Гмбх Соединения с нематоцидной активностью
PL2782565T3 (pl) * 2011-11-25 2020-08-24 Bayer Intellectual Property Gmbh Zastosowanie arylo- i heteroarylokarboksyamidów jako środki endopasożytobójcze
TW201427947A (zh) * 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺
TWI598325B (zh) 2012-10-12 2017-09-11 H 朗德貝克公司 苯甲醯胺類

Similar Documents

Publication Publication Date Title
JP2019081762A5 (enExample)
HRP20210949T1 (hr) Spojevi i sastavi za moduliranje aktivnosti egfr mutant kinaze
JP2016534134A5 (enExample)
JP2017502940A5 (enExample)
JP2015537020A5 (enExample)
JP2017537949A5 (enExample)
JP2019509291A5 (enExample)
PE20180227A1 (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
HRP20251220T1 (hr) Derivati bipirazola kao jak inhibitori
RU2015113320A (ru) Бензамиды
JP2016536363A5 (enExample)
JP2015504081A5 (enExample)
JP2016536364A5 (enExample)
JP2017511794A5 (enExample)
RU2015151502A (ru) Химические соединения
JP2017504635A5 (enExample)
JP2014139226A5 (enExample)
HRP20170638T1 (hr) MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI
JP2016519165A5 (enExample)
JP2017517565A5 (enExample)
JP2012530705A5 (enExample)
JP2020502092A5 (enExample)
HRP20161177T1 (hr) Modulator glukagonskog receptora
JP2017514910A5 (enExample)
JP2014510147A5 (enExample)